首页 > 最新文献

Research and Reports in Tropical Medicine最新文献

英文 中文
The State of Affairs in Post-Exposure Leprosy Prevention: A Descriptive Meta-Analysis on Immuno- and Chemo-Prophylaxis. 暴露后麻风病预防的现状:关于免疫和化学预防的描述性元分析。
IF 3.1 Q2 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2020-10-15 eCollection Date: 2020-01-01 DOI: 10.2147/RRTM.S190300
Anne Schoenmakers, Liesbeth Mieras, Teky Budiawan, Wim H van Brakel
<p><strong>Objective: </strong>Annually, over 200,000 people are diagnosed with leprosy, also called Hansen's disease. This number has been relatively stable over the past years. Progress has been made in the fields of chemoprophylaxis and immunoprophylaxis to prevent leprosy, with a primary focus on close contacts of patients. In this descriptive meta-analysis, we summarize the evidence and identify knowledge gaps regarding post-exposure prophylaxis against leprosy.</p><p><strong>Methods: </strong>A systematic literature search according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) methodology was conducted by searching the medical scientific databases Cochrane, Embase, Pubmed/MEDLINE, Research Gate, Scopus and Web of Science on Jan. 22, 2020, using a combination of synonyms for index terms in four languages: "leprosy" and "population" or "contacts" and "prevention" or "prophylaxis." Subsequently, Infolep.org and Google Scholar were searched and the "snowball method" was used to retrieve other potentially relevant literature. The found articles were screened for eligibility using predetermined inclusion and exclusion criteria.</p><p><strong>Results: </strong>After deduplication, 1,515 articles were screened, and 125 articles were included in this descriptive meta-analysis. Immunoprophylaxis by bacillus Calmette-Guérin (BCG) vaccination is known to provide protection against leprosy. The protection it offers is higher in household contacts of leprosy patients compared with the general population and is seen to decline over time. Contact follow-up screening is important in the first period after BCG administration, as a substantial number of new leprosy patients presents three months post-vaccination. Evidence for the benefit of re-vaccination is conflicting. The World Health Organization (WHO) included BCG in its Guidelines for the Diagnosis, Treatment and Prevention of Leprosy by stating that BCG at birth should be maintained in at least all leprosy high-burden regions. Literature shows that several vaccination interventions with other immunoprophylactic agents demonstrate similar or slightly less efficacy in leprosy risk reduction compared with BCG. However, most of these studies do not exclusively focus on post-exposure prophylaxis. Two vaccines are considered future candidates for leprosy prophylaxis: <i>Mycobacterium indicus pranii</i> (<i>MiP</i>) and LepVax. For chemoprophylaxis, trials were performed with dapsone/acedapsone, rifampicin, and ROM, a combination of rifampicin, ofloxacin, and minocycline. Single-dose rifampicin is favored as post-exposure prophylaxis, abbreviated as SDR-PEP. It demonstrated a protective effect of 57% in the first two years after administration to contacts of leprosy patients. It is inexpensive, and adverse events are rare. The risk of SDR-PEP inducing rifampicin resistance is considered negligible, but continuous monitoring in accordance with WHO policies should be encour
目标:每年有 20 多万人被诊断出患有麻风病(又称汉森氏病)。这一数字在过去几年中相对稳定。在预防麻风病的化学预防和免疫预防领域取得了进展,其主要重点是麻风病人的密切接触者。在这项描述性荟萃分析中,我们总结了有关麻风病暴露后预防的证据,并找出了相关知识的不足之处:2020年1月22日,根据系统综述和荟萃分析首选报告项目(PRISMA)方法,使用四种语言的同义词组合检索了医学科学数据库Cochrane、Embase、Pubmed/MEDLINE、Research Gate、Scopus和Web of Science,进行了系统文献检索:"麻风病 "和 "人群 "或 "接触者 "以及 "预防 "或 "预防性治疗"。随后,还搜索了 Infolep.org 和谷歌学术,并采用 "滚雪球法 "检索其他可能相关的文献。根据预先确定的纳入和排除标准对找到的文章进行资格筛选:结果:经过重复筛选,共筛选出 1,515 篇文章,其中 125 篇文章被纳入此次描述性荟萃分析。众所周知,接种卡介苗可预防麻风病。与普通人群相比,麻风病人的家庭接触者接种卡介苗的保护率更高,而且随着时间的推移,保护率会逐渐下降。在接种卡介苗后的第一阶段,接触者随访筛查非常重要,因为大量新麻风病人会在接种后三个月发病。有关再次接种麻风疫苗的益处的证据并不一致。世界卫生组织(WHO)将卡介苗纳入《麻风病诊断、治疗和预防指南》,指出至少在所有麻风病高负担地区都应坚持在出生时接种卡介苗。文献显示,与卡介苗相比,使用其他免疫预防制剂的几种疫苗接种干预措施在降低麻风病风险方面的效果相似或略逊一筹。不过,这些研究大多并不只关注暴露后预防。有两种疫苗被认为是未来麻风病预防的候选疫苗:麻风分枝杆菌(MiP)和麻风疫苗(LepVax)。在化学预防方面,使用了达泊松/阿达帕松、利福平和 ROM(利福平、氧氟沙星和米诺环素的复方制剂)进行了试验。单剂量利福平作为暴露后预防药物(简称 SDR-PEP)受到青睐。在对麻风病人的接触者用药后的头两年中,其保护效果达到 57%。它价格低廉,不良反应也很少发生。SDR-PEP诱发利福平耐药性的风险可忽略不计,但应鼓励根据世界卫生组织的政策进行持续监测。研究发现,将接触筛查和SDR-PEP管理纳入不同的麻风病控制项目是可行的,并且广为接受。自2018年起,SDR-PEP被纳入《世界卫生组织麻风病诊断、治疗和预防指南》:在预防麻风病人接触者的化学预防和免疫预防领域已取得进展。投资疫苗研究(如 LepVax 和 MiP)以及加强结核病研究小组与麻风病研究小组之间的协调非常重要。SDR-PEP作为一种化学预防药物很有前景,应进一步推广使用。需要在以下方面开展更多的化学预防研究:强化用药方案;在不同(流行病学)环境中采取干预措施,包括集中大规模给药(fMDA);针对不同接触类型采取特定方法;与筛查变异方法和便于现场使用的快速检测相结合(如果将来有的话);社区和医务人员教育;持续进行抗生素耐药性监测;以及在卡介苗注射前使用 SDR-PEP 进行化学预防。此外,在全国范围内进行麻风病预防药物注册,以及在全球范围内以低价或免费提供预防药物,对于麻风病预防措施(如 SDR-PEP 和新型疫苗)的实施和进一步推广非常重要。
{"title":"The State of Affairs in Post-Exposure Leprosy Prevention: A Descriptive Meta-Analysis on Immuno- and Chemo-Prophylaxis.","authors":"Anne Schoenmakers, Liesbeth Mieras, Teky Budiawan, Wim H van Brakel","doi":"10.2147/RRTM.S190300","DOIUrl":"10.2147/RRTM.S190300","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;Annually, over 200,000 people are diagnosed with leprosy, also called Hansen's disease. This number has been relatively stable over the past years. Progress has been made in the fields of chemoprophylaxis and immunoprophylaxis to prevent leprosy, with a primary focus on close contacts of patients. In this descriptive meta-analysis, we summarize the evidence and identify knowledge gaps regarding post-exposure prophylaxis against leprosy.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;A systematic literature search according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) methodology was conducted by searching the medical scientific databases Cochrane, Embase, Pubmed/MEDLINE, Research Gate, Scopus and Web of Science on Jan. 22, 2020, using a combination of synonyms for index terms in four languages: \"leprosy\" and \"population\" or \"contacts\" and \"prevention\" or \"prophylaxis.\" Subsequently, Infolep.org and Google Scholar were searched and the \"snowball method\" was used to retrieve other potentially relevant literature. The found articles were screened for eligibility using predetermined inclusion and exclusion criteria.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;After deduplication, 1,515 articles were screened, and 125 articles were included in this descriptive meta-analysis. Immunoprophylaxis by bacillus Calmette-Guérin (BCG) vaccination is known to provide protection against leprosy. The protection it offers is higher in household contacts of leprosy patients compared with the general population and is seen to decline over time. Contact follow-up screening is important in the first period after BCG administration, as a substantial number of new leprosy patients presents three months post-vaccination. Evidence for the benefit of re-vaccination is conflicting. The World Health Organization (WHO) included BCG in its Guidelines for the Diagnosis, Treatment and Prevention of Leprosy by stating that BCG at birth should be maintained in at least all leprosy high-burden regions. Literature shows that several vaccination interventions with other immunoprophylactic agents demonstrate similar or slightly less efficacy in leprosy risk reduction compared with BCG. However, most of these studies do not exclusively focus on post-exposure prophylaxis. Two vaccines are considered future candidates for leprosy prophylaxis: &lt;i&gt;Mycobacterium indicus pranii&lt;/i&gt; (&lt;i&gt;MiP&lt;/i&gt;) and LepVax. For chemoprophylaxis, trials were performed with dapsone/acedapsone, rifampicin, and ROM, a combination of rifampicin, ofloxacin, and minocycline. Single-dose rifampicin is favored as post-exposure prophylaxis, abbreviated as SDR-PEP. It demonstrated a protective effect of 57% in the first two years after administration to contacts of leprosy patients. It is inexpensive, and adverse events are rare. The risk of SDR-PEP inducing rifampicin resistance is considered negligible, but continuous monitoring in accordance with WHO policies should be encour","PeriodicalId":21138,"journal":{"name":"Research and Reports in Tropical Medicine","volume":"11 ","pages":"97-117"},"PeriodicalIF":3.1,"publicationDate":"2020-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a6/02/rrtm-11-97.PMC7573302.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38546066","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Onchocerciasis Elimination: Progress and Challenges. 消除盘尾丝虫病:进展与挑战。
IF 3.1 Q2 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2020-10-07 eCollection Date: 2020-01-01 DOI: 10.2147/RRTM.S224364
Thomson Lakwo, David Oguttu, Tony Ukety, Rory Post, Didier Bakajika

Onchocerciasis is a parasitic infection caused by the filarial nematode Onchocerca volvulus and transmitted through the bites of black flies of the genus Similium that breed in rivers and streams. The impact of mass treatment with ivermectin and supplemented by vector control in some countries has changed the global scene of onchocerciasis. There has been reported progress made in elimination of onchocerciasis in central and southern American countries and in some localities in Africa. The target for elimination in the Americas has been set at 2022 while for 12 countries in Africa this is expected in 2030. This review was conducted to examine the current status of onchocerciasis elimination at the global level and report on progress made. Literature searches were made through PubMed, articles in English or English abstracts, reports and any other relevant articles related to the subject. The global burden of onchocerciasis is progressively reducing and is no longer a public health problem in some regions. However, programs are challenged with a range of issues: cross-border transmission, diagnostic tools, Loa loa co-endemicity, limited workforce in entomology and maintaining enthusiasm among community drug distributors. More concerted effort using appropriate tools is required to overcome the challenges.

盘尾丝虫病是一种由盘尾丝虫病引起的寄生虫感染,通过在河流和溪流中繁殖的类似属黑蝇的叮咬传播。在一些国家使用伊维菌素进行大规模治疗并辅以病媒控制的影响改变了盘尾丝虫病的全球情况。据报告,中美洲和南美洲国家以及非洲一些地方在消灭盘尾丝虫病方面取得了进展。美洲的消除目标已确定为2022年,而非洲的12个国家预计在2030年实现这一目标。本次审查的目的是审查全球消除盘尾丝虫病的现状,并报告取得的进展。文献检索通过PubMed、英文文章或英文摘要、报告和与主题相关的任何其他相关文章进行。盘尾丝虫病的全球负担正在逐步减轻,在某些区域已不再是一个公共卫生问题。然而,该计划面临着一系列问题的挑战:跨境传播、诊断工具、罗阿罗亚共流行、昆虫学方面的人力资源有限以及社区药物分销商的热情。需要更协调一致的努力,使用适当的工具来克服这些挑战。
{"title":"Onchocerciasis Elimination: Progress and Challenges.","authors":"Thomson Lakwo,&nbsp;David Oguttu,&nbsp;Tony Ukety,&nbsp;Rory Post,&nbsp;Didier Bakajika","doi":"10.2147/RRTM.S224364","DOIUrl":"https://doi.org/10.2147/RRTM.S224364","url":null,"abstract":"<p><p>Onchocerciasis is a parasitic infection caused by the filarial nematode <i>Onchocerca volvulus</i> and transmitted through the bites of black flies of the genus <i>Similium</i> that breed in rivers and streams. The impact of mass treatment with ivermectin and supplemented by vector control in some countries has changed the global scene of onchocerciasis. There has been reported progress made in elimination of onchocerciasis in central and southern American countries and in some localities in Africa. The target for elimination in the Americas has been set at 2022 while for 12 countries in Africa this is expected in 2030. This review was conducted to examine the current status of onchocerciasis elimination at the global level and report on progress made. Literature searches were made through PubMed, articles in English or English abstracts, reports and any other relevant articles related to the subject. The global burden of onchocerciasis is progressively reducing and is no longer a public health problem in some regions. However, programs are challenged with a range of issues: cross-border transmission, diagnostic tools, <i>Loa loa</i> co-endemicity, limited workforce in entomology and maintaining enthusiasm among community drug distributors. More concerted effort using appropriate tools is required to overcome the challenges.</p>","PeriodicalId":21138,"journal":{"name":"Research and Reports in Tropical Medicine","volume":"11 ","pages":"81-95"},"PeriodicalIF":3.1,"publicationDate":"2020-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2147/RRTM.S224364","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38546065","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 34
In vitro Effects of Punica granatum Ellagitannins on Adult Worms of Schistosoma mansoni. 石榴鞣花单宁对曼氏血吸虫成虫的体外作用。
IF 3.1 Q2 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2020-10-05 eCollection Date: 2020-01-01 DOI: 10.2147/RRTM.S248604
Khalid H Abozeid, Mohamed F El-Badawy, Soheir Mahmoud, Mohamed M Shohayeb

Schistosomiasis ranks second behind malaria in terms of overall morbidity and mortality. We evaluated the lethal effect of Punica granatum ellagitannins, extracted from the fruit rind, placenta and barks of the root and stem, on adult worms of Schistosoma mansoni (S. mansoni). All four ellagitannins were lethal to S. mansoni adult worms. However, while the rind ellagitannins were the most potent, placental ellagitannins were the least. Rind ellagitannins were capable of killing 40% of adult worms at a concentration of 25µg/mL after 5 days. The killing of 100% of the worms was achievable by rind ellagitannins at a concentration of 50µg/mL after 5 days. The LD50S of the rind ellagitannins after 96h and 120h were 41.25 µg/mL and 28.73 respectively. Ellagitannins-treated worms suffered from erosions, wrinkles, swellings and losses, degenerations of the surface tubercles and tegument. In addition, ellagitannins induced deformation and degradation of oral and ventral suckers and degenerations in the muscles of worms. Ellagitannins also caused a separation of coupled worms and reduction of their motility. Data obtained suggest that ellagitannins of pomegranate could be considered as a cheap candidate for the treatment of schistosomiasis.

就总体发病率和死亡率而言,血吸虫病排名第二,仅次于疟疾。研究了从石榴果皮、果皮、根茎皮中提取的石榴鞣花丹宁对曼氏血吸虫成虫的杀伤作用。四种鞣花单宁对曼氏梭菌成虫均有致死作用。然而,虽然果皮鞣花单宁是最有效的,胎盘鞣花单宁是最不有效的。当浓度为25µg/mL时,5天后,鞣花单宁能杀死40%的成虫。以50µg/mL的浓度剥皮鞣花单宁,5天后可达到100%的杀虫率。96h和120h后鞣花单宁的LD50S分别为41.25µg/mL和28.73µg/mL。鞣花单宁处理的蠕虫遭受侵蚀,皱纹,肿胀和损失,表面结节和被皮退化。此外,鞣花单宁还会引起蠕虫口腔和腹侧吸盘的变形和退化,以及肌肉的退化。鞣花丹宁还引起了偶联蠕虫的分离和它们运动能力的降低。所获得的数据表明石榴鞣花单宁可以被认为是一种廉价的治疗血吸虫病的候选药物。
{"title":"In vitro Effects of <i>Punica granatum</i> Ellagitannins on Adult Worms of <i>Schistosoma mansoni</i>.","authors":"Khalid H Abozeid,&nbsp;Mohamed F El-Badawy,&nbsp;Soheir Mahmoud,&nbsp;Mohamed M Shohayeb","doi":"10.2147/RRTM.S248604","DOIUrl":"https://doi.org/10.2147/RRTM.S248604","url":null,"abstract":"<p><p>Schistosomiasis ranks second behind malaria in terms of overall morbidity and mortality. We evaluated the lethal effect of <i>Punica granatum</i> ellagitannins, extracted from the fruit rind, placenta and barks of the root and stem, on adult worms of <i>Schistosoma mansoni (S. mansoni)</i>. All four ellagitannins were lethal to <i>S. mansoni</i> adult worms. However, while the rind ellagitannins were the most potent, placental ellagitannins were the least. Rind ellagitannins were capable of killing 40% of adult worms at a concentration of 25µg/mL after 5 days. The killing of 100% of the worms was achievable by rind ellagitannins at a concentration of 50µg/mL after 5 days. The LD<sub>50S</sub> of the rind ellagitannins after 96h and 120h were 41.25 µg/mL and 28.73 respectively. Ellagitannins-treated worms suffered from erosions, wrinkles, swellings and losses, degenerations of the surface tubercles and tegument. In addition, ellagitannins induced deformation and degradation of oral and ventral suckers and degenerations in the muscles of worms. Ellagitannins also caused a separation of coupled worms and reduction of their motility. Data obtained suggest that ellagitannins of pomegranate could be considered as a cheap candidate for the treatment of schistosomiasis.</p>","PeriodicalId":21138,"journal":{"name":"Research and Reports in Tropical Medicine","volume":"11 ","pages":"73-80"},"PeriodicalIF":3.1,"publicationDate":"2020-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/0f/66/rrtm-11-73.PMC7547181.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38546064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Off-Label Use of Chloroquine and Hydroxychloroquine for COVID-19 Treatment in Africa Against WHO Recommendation. 根据世卫组织建议,在非洲超说明书使用氯喹和羟氯喹治疗COVID-19。
IF 3.1 Q2 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2020-09-17 eCollection Date: 2020-01-01 DOI: 10.2147/RRTM.S269936
Anteneh Belayneh
Abstract COVID-19 is continuing as a big challenge for the globe and several types of research are continued to find safe and effective treatment and preventive options. Although there is a lack of conclusive evidence of their benefit, there is worldwide controversy to use anti-malarial drugs, hydroxychloroquine and chloroquine, for the treatment of COVID-19. FDA issued an emergency use authorization to the use of these drugs for the treatment of COVID-19. On the contrary to the FDA, the European Medicines Agency has warned against the widespread use of these drugs to treat COVID-19. Finally, the WHO declared that clinical trials on these drugs are halted after the devastating findings of the study published in the medical journal called The Lancet. Against this fact, there are several rumors about the irresponsible use of these drugs in Africa for the treatment of COVID-19. This work aimed to review the off-label use of these drugs for the treatment of COVID-19 in African countries against WHO recommendation. Data on the use of these drugs for the treatment of COVID-19 in African countries were searched from credible sources including Scopus, PubMed, Hindawi, Google Scholar, and from local and international media. The study showed that many African countries have already approved at the national level to use these drugs to treat COVID-19 by opposing WHO warnings. In addition to this, falsified and substandard chloroquine products started to emerge in some African countries. The health sectors of the African government should critically compare the risks and benefits before using these drugs. The WHO and African drug regulatory organizations should intervene to stop the off-label use practice of these drugs against the licensed purpose and distribution of falsified and substandard products in the continent.
2019冠状病毒病仍是全球面临的一大挑战,人们正在继续进行几种类型的研究,以寻找安全有效的治疗和预防方案。虽然缺乏确凿证据证明抗疟药的益处,但使用抗疟药羟氯喹和氯喹治疗COVID-19在世界范围内存在争议。FDA发布了使用这些药物治疗COVID-19的紧急使用授权。与FDA相反,欧洲药品管理局警告不要广泛使用这些药物来治疗COVID-19。最后,世卫组织宣布,在医学杂志《柳叶刀》(the Lancet)上发表了一项毁灭性的研究结果后,这些药物的临床试验停止了。与此相反,有一些传言称,非洲不负责任地使用这些药物治疗COVID-19。这项工作旨在根据世卫组织的建议,审查这些药物在非洲国家治疗COVID-19的适应症外使用情况。从Scopus、PubMed、Hindawi、Google Scholar等可靠来源以及当地和国际媒体检索了非洲国家使用这些药物治疗COVID-19的数据。该研究表明,许多非洲国家已经通过反对世卫组织的警告,在国家层面批准使用这些药物治疗COVID-19。此外,一些非洲国家开始出现氯喹假冒伪劣产品。在使用这些药物之前,非洲政府的卫生部门应该严格比较风险和收益。世卫组织和非洲药物监管组织应进行干预,制止这些药物违反许可用途的说明书外使用做法,并制止在非洲大陆分发伪造和不合格产品。
{"title":"Off-Label Use of Chloroquine and Hydroxychloroquine for COVID-19 Treatment in Africa Against WHO Recommendation.","authors":"Anteneh Belayneh","doi":"10.2147/RRTM.S269936","DOIUrl":"https://doi.org/10.2147/RRTM.S269936","url":null,"abstract":"Abstract COVID-19 is continuing as a big challenge for the globe and several types of research are continued to find safe and effective treatment and preventive options. Although there is a lack of conclusive evidence of their benefit, there is worldwide controversy to use anti-malarial drugs, hydroxychloroquine and chloroquine, for the treatment of COVID-19. FDA issued an emergency use authorization to the use of these drugs for the treatment of COVID-19. On the contrary to the FDA, the European Medicines Agency has warned against the widespread use of these drugs to treat COVID-19. Finally, the WHO declared that clinical trials on these drugs are halted after the devastating findings of the study published in the medical journal called The Lancet. Against this fact, there are several rumors about the irresponsible use of these drugs in Africa for the treatment of COVID-19. This work aimed to review the off-label use of these drugs for the treatment of COVID-19 in African countries against WHO recommendation. Data on the use of these drugs for the treatment of COVID-19 in African countries were searched from credible sources including Scopus, PubMed, Hindawi, Google Scholar, and from local and international media. The study showed that many African countries have already approved at the national level to use these drugs to treat COVID-19 by opposing WHO warnings. In addition to this, falsified and substandard chloroquine products started to emerge in some African countries. The health sectors of the African government should critically compare the risks and benefits before using these drugs. The WHO and African drug regulatory organizations should intervene to stop the off-label use practice of these drugs against the licensed purpose and distribution of falsified and substandard products in the continent.","PeriodicalId":21138,"journal":{"name":"Research and Reports in Tropical Medicine","volume":"11 ","pages":"61-72"},"PeriodicalIF":3.1,"publicationDate":"2020-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2147/RRTM.S269936","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38521664","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 43
Malaria Morbidities Following Universal Coverage Campaign for Long-Lasting Insecticidal Nets: A Case Study in Ukerewe District, Northwestern Tanzania. 长效驱虫蚊帐普及运动后的疟疾发病率:坦桑尼亚西北部Ukerewe地区的案例研究
IF 3.1 Q2 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2020-07-29 eCollection Date: 2020-01-01 DOI: 10.2147/RRTM.S248834
Anthony Kapesa, Namanya Basinda, Elias C Nyanza, Joshua Monge, Sospatro E Ngallaba, Joseph R Mwanga, Eliningaya J Kweka

Background: Surveillance of the clinical morbidity of malaria remains key for disease monitoring for subsequent development of appropriate interventions. This case study presents the current status of malaria morbidities following a second round of mass distribution of long-lasting insecticidal nets (LLINs) on Ukerewe Island, northwestern Tanzania.

Methods: A retrospective review of health-facility registers to determine causes of inpatient morbidities for every admitted child aged <5 years was conducted to ascertain the contribution of malaria before and after distribution of LLINs. This review was conducted from August 2016 to July 2018 in three selected health facilities. To determine the trend of malaria admissions in the selected facilities, additional retrospective collection of all malaria and other causes of admission was conducted for both <5- and >5-year-old patients from July 2014 to June 2018. For comparison purposes, monthly admissions of malaria and other causes from all health facilities in the district were also collected. Moreover, an LLIN-coverage study was conducted among randomly selected households (n=684).

Results: Between August 2016 and July 2018, malaria was the leading cause of inpatient morbidity, accounting for 44.1% and 20.3% among patients <5 and >5 years old, respectively. Between October 2017 and January 2018, the mean number of admissions of patients aged <5 years increased 2.7-fold at one health center and 1.02-fold for all admissions in the district. Additionally, approximately half the households in the study area had poor of LLIN coverage 1 year after mass distribution.

Conclusion: This trend analysis of inpatient morbidities among children aged <5 years revealed an upsurge in malaria admissions in some health facilities in the district, despite LLIN intervention. This suggests the occurrence of an unnoticed outbreak of malaria admissions in all health facilities.

背景:疟疾临床发病率的监测仍然是疾病监测的关键,以便随后制定适当的干预措施。本案例研究介绍了在坦桑尼亚西北部Ukerewe岛第二轮大规模分发长效驱虫蚊帐(LLINs)后疟疾发病率的现状。方法:回顾性审查卫生机构登记,以确定2014年7月至2018年6月每个入院的5岁儿童住院发病率的原因。为了进行比较,还收集了该地区所有卫生设施每月收治的疟疾和其他原因的病例。此外,在随机选择的家庭(n=684)中进行了一项llin覆盖率研究。结果:2016年8月至2018年7月,疟疾是住院患者发病的主要原因,在5岁患者中分别占44.1%和20.3%。2017年10月至2018年1月期间,住院儿童的平均老年住院人数。结论:本文分析了老年儿童住院发病率的趋势
{"title":"Malaria Morbidities Following Universal Coverage Campaign for Long-Lasting Insecticidal Nets: A Case Study in Ukerewe District, Northwestern Tanzania.","authors":"Anthony Kapesa,&nbsp;Namanya Basinda,&nbsp;Elias C Nyanza,&nbsp;Joshua Monge,&nbsp;Sospatro E Ngallaba,&nbsp;Joseph R Mwanga,&nbsp;Eliningaya J Kweka","doi":"10.2147/RRTM.S248834","DOIUrl":"https://doi.org/10.2147/RRTM.S248834","url":null,"abstract":"<p><strong>Background: </strong>Surveillance of the clinical morbidity of malaria remains key for disease monitoring for subsequent development of appropriate interventions. This case study presents the current status of malaria morbidities following a second round of mass distribution of long-lasting insecticidal nets (LLINs) on Ukerewe Island, northwestern Tanzania.</p><p><strong>Methods: </strong>A retrospective review of health-facility registers to determine causes of inpatient morbidities for every admitted child aged <5 years was conducted to ascertain the contribution of malaria before and after distribution of LLINs. This review was conducted from August 2016 to July 2018 in three selected health facilities. To determine the trend of malaria admissions in the selected facilities, additional retrospective collection of all malaria and other causes of admission was conducted for both <5- and >5-year-old patients from July 2014 to June 2018. For comparison purposes, monthly admissions of malaria and other causes from all health facilities in the district were also collected. Moreover, an LLIN-coverage study was conducted among randomly selected households (n=684).</p><p><strong>Results: </strong>Between August 2016 and July 2018, malaria was the leading cause of inpatient morbidity, accounting for 44.1% and 20.3% among patients <5 and >5 years old, respectively. Between October 2017 and January 2018, the mean number of admissions of patients aged <5 years increased 2.7-fold at one health center and 1.02-fold for all admissions in the district. Additionally, approximately half the households in the study area had poor of LLIN coverage 1 year after mass distribution.</p><p><strong>Conclusion: </strong>This trend analysis of inpatient morbidities among children aged <5 years revealed an upsurge in malaria admissions in some health facilities in the district, despite LLIN intervention. This suggests the occurrence of an unnoticed outbreak of malaria admissions in all health facilities.</p>","PeriodicalId":21138,"journal":{"name":"Research and Reports in Tropical Medicine","volume":"11 ","pages":"53-60"},"PeriodicalIF":3.1,"publicationDate":"2020-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2147/RRTM.S248834","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38268395","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and Predictors of CD4+ T-Lymphocytopenia Among HIV-Negative Tuberculosis Patients in Uganda. 乌干达hiv阴性结核患者CD4+ t淋巴细胞减少的患病率和预测因素
IF 3.1 Q2 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2020-06-25 eCollection Date: 2020-01-01 DOI: 10.2147/RRTM.S252550
Joseph Baruch Baluku, Joseph Musaazi, Rose Mulwana, Araali Robert Mugabo, Felix Bongomin, Winceslaus Katagira

Purpose: CD4+ T-lymphocytopenia is a risk for tuberculosis (TB) infection, reactivation and severe disease. We sought to determine the prevalence and predictors of CD4 T-lymphocytopenia among HIV-negative patients with bacteriologically confirmed TB in Uganda.

Patients and methods: Eligible participants were adult HIV-negative patients with bacteriologically confirmed TB at the National TB Treatment Centre in Uganda. CD4+ and CD8+ T-lymphocyte counts were determined by flow cytometry. We defined CD4+ T-lymphocytopenia as a CD4+ T-lymphocyte count of <418 cells/mm3 as per the population estimate for Ugandans. We performed logistic regression analysis to determine predictors of CD4+ T-lymphocytopenia.

Results: We enrolled 216 participants whose mean age (standard deviation (±SD)) was 32.5 (±12.1) years, of whom 146 (67.6%) were males. The prevalence of CD4+ T-lymphocytopenia was 25% (54/216) (95% confidence interval (CI): 19.6-31.2%). Patients with anaemia (adjusted odds ratio (aOR): 3.83, 95% CI: 1.59-9.23, p = 0.003), weight loss (aOR: 3.61, 95% CI: 1.07-12.23, p = 0.039) and a low CD8+ T-cell count (aOR: 6.10, 95% CI: 2.68-13.89, p < 0.001) were more likely to have CD4+ T-lymphocytopenia while those with monocytosis (aOR: 0.35, 95% CI: 0.14-0.89, p = 0.028) were less likely to have CD4+ T-lymphocytopenia.

Conclusion: There was a high prevalence of CD4+ T-lymphocytopenia among HIV-negative TB patients. Patients with weight loss, anaemia and a low CD8+ count were more likely to have CD4+ T-lymphocytopenia while those with monocytosis were less likely to have CD4+ lymphocytopenia. The findings suggest that CD4+ lymphocytopenia is indicative of severe disease and globally impaired cell-mediated immune responses against TB.

目的:CD4+ t淋巴细胞减少症是结核病(TB)感染、再激活和严重疾病的危险因素。我们试图确定在乌干达细菌学确诊的hiv阴性结核病患者中CD4 t淋巴细胞减少症的患病率和预测因素。患者和方法:符合条件的参与者是乌干达国家结核病治疗中心细菌学证实的成年艾滋病毒阴性结核病患者。流式细胞术检测CD4+、CD8+ t淋巴细胞计数。我们将CD4+ t淋巴细胞减少症定义为CD4+ t淋巴细胞计数为3,根据乌干达人口估计。我们进行了逻辑回归分析,以确定CD4+ t淋巴细胞减少症的预测因素。结果:我们招募了216名参与者,平均年龄(标准差(±SD))为32.5(±12.1)岁,其中146名(67.6%)为男性。CD4+ t淋巴细胞减少的患病率为25%(54/216)(95%可信区间(CI): 19.6-31.2%)。贫血(校正优势比(aOR): 3.83, 95% CI: 1.59-9.23, p = 0.003)、体重减轻(aOR: 3.61, 95% CI: 1.07-12.23, p = 0.039)和低CD8+ t细胞计数(aOR: 6.10, 95% CI: 2.68-13.89, p < 0.001)的患者更容易发生CD4+ t淋巴细胞减少症,而单核细胞增多症(aOR: 0.35, 95% CI: 0.14-0.89, p = 0.028)的患者更不容易发生CD4+ t淋巴细胞减少症。结论:hiv阴性结核患者CD4+ t淋巴细胞减少率较高。体重减轻、贫血和CD8+计数低的患者更容易发生CD4+ t淋巴细胞减少症,而单核细胞增多症患者更不容易发生CD4+淋巴细胞减少症。研究结果表明,CD4+淋巴细胞减少症表明严重疾病和细胞介导的结核病免疫反应全面受损。
{"title":"Prevalence and Predictors of CD4+ T-Lymphocytopenia Among HIV-Negative Tuberculosis Patients in Uganda.","authors":"Joseph Baruch Baluku,&nbsp;Joseph Musaazi,&nbsp;Rose Mulwana,&nbsp;Araali Robert Mugabo,&nbsp;Felix Bongomin,&nbsp;Winceslaus Katagira","doi":"10.2147/RRTM.S252550","DOIUrl":"https://doi.org/10.2147/RRTM.S252550","url":null,"abstract":"<p><strong>Purpose: </strong>CD4+ T-lymphocytopenia is a risk for tuberculosis (TB) infection, reactivation and severe disease. We sought to determine the prevalence and predictors of CD4 T-lymphocytopenia among HIV-negative patients with bacteriologically confirmed TB in Uganda.</p><p><strong>Patients and methods: </strong>Eligible participants were adult HIV-negative patients with bacteriologically confirmed TB at the National TB Treatment Centre in Uganda. CD4+ and CD8+ T-lymphocyte counts were determined by flow cytometry. We defined CD4+ T-lymphocytopenia as a CD4+ T-lymphocyte count of <418 cells/mm<sup>3</sup> as per the population estimate for Ugandans. We performed logistic regression analysis to determine predictors of CD4+ T-lymphocytopenia.</p><p><strong>Results: </strong>We enrolled 216 participants whose mean age (standard deviation (±SD)) was 32.5 (±12.1) years, of whom 146 (67.6%) were males. The prevalence of CD4+ T-lymphocytopenia was 25% (54/216) (95% confidence interval (CI): 19.6-31.2%). Patients with anaemia (adjusted odds ratio (aOR): 3.83, 95% CI: 1.59-9.23, p = 0.003), weight loss (aOR: 3.61, 95% CI: 1.07-12.23, p = 0.039) and a low CD8+ T-cell count (aOR: 6.10, 95% CI: 2.68-13.89, p < 0.001) were more likely to have CD4+ T-lymphocytopenia while those with monocytosis (aOR: 0.35, 95% CI: 0.14-0.89, p = 0.028) were less likely to have CD4+ T-lymphocytopenia.</p><p><strong>Conclusion: </strong>There was a high prevalence of CD4+ T-lymphocytopenia among HIV-negative TB patients. Patients with weight loss, anaemia and a low CD8+ count were more likely to have CD4+ T-lymphocytopenia while those with monocytosis were less likely to have CD4+ lymphocytopenia. The findings suggest that CD4+ lymphocytopenia is indicative of severe disease and globally impaired cell-mediated immune responses against TB.</p>","PeriodicalId":21138,"journal":{"name":"Research and Reports in Tropical Medicine","volume":"11 ","pages":"45-51"},"PeriodicalIF":3.1,"publicationDate":"2020-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2147/RRTM.S252550","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38110182","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Retrospective Analysis of Malaria Cases in a Potentially High Endemic Area of Morogoro Rural District, Eastern Tanzania. 坦桑尼亚东部莫罗戈罗农村地区潜在高流行区疟疾病例回顾性分析
IF 3.1 Q2 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2020-06-12 eCollection Date: 2020-01-01 DOI: 10.2147/RRTM.S254577
Joseph N Aikambe, Ladslaus L Mnyone

Background: Malaria is increasingly characterized by appreciable fine-scale variability in ecology and topography, and it is likely that we are missing some salient foci with unprecedented malaria transmission intensity in different parts of Tanzania. Therefore, efforts aimed at identifying area-specific malaria situation and intervening are needed to preserve the realized health gains and achieve elimination. Mkuyuni and Kiroka, adjacent wards within Morogoro Rural District, are purported to form one of such foci.

Patients and methods: A retrospective study was conducted to determine six-year (2014-2019) malaria prevalence rates based on outpatients and laboratory registers obtained from two health facilities, one per ward, carrying out diagnosis of malaria either through microscopy or malaria rapid diagnostic test (mRDT). These data were checked for completeness before carrying out statistical analysis.

Results: Overall, 35,386 (46.19%) out of 76,604 patients were positive for malaria. The average proportion of malaria cases was significantly higher in Mkuyuni (51.23%; n=19,438) than Kiroka (41.21%; n = 15,938) (P <0.001). Females were more affected than males (P <0.001);, and irrespective of the sex, most malaria cases were recorded in children <5 years of age (P <0.001) except at Mkuyuni. Malaria was recorded virtually all year round; however, the highest proportion of cases was recorded in April and July (P <0.001).

Conclusion: This study revealed high malaria endemicity in Mkuyuni and Kiroka, with prevalence rate as high as 60.98%, which is far higher than the overall national average prevalence of 9%. More studies are needed in these and other putatively high endemic foci in Tanzania in order to inform the future course of action in disease surveillance and control.

背景:疟疾在生态和地形上的细微变异性越来越明显,我们很可能在坦桑尼亚不同地区错过了一些具有前所未有的疟疾传播强度的突出焦点。因此,需要努力查明特定地区的疟疾情况并进行干预,以保持已实现的保健成果并实现消除。莫罗戈罗农村区内相邻的姆库尤尼和基罗卡据称就是其中一个重灾区。患者和方法:开展了一项回顾性研究,根据通过显微镜或疟疾快速诊断测试(mRDT)进行疟疾诊断的两个卫生机构(每个病房一个)获得的门诊患者和实验室登记册,确定6年(2014-2019年)疟疾患病率。在进行统计分析之前,对这些数据进行了完整性检查。结果:76,604例患者中,35,386例(46.19%)疟疾阳性。姆库尤尼的疟疾病例平均比例显著高于其他地区(51.23%;n= 19438)比Kiroka (41.21%;结论:本研究显示姆库尤尼和基罗卡地区疟疾高发,流行率高达60.98%,远高于全国平均水平9%。需要对坦桑尼亚的这些和其他假定的高流行疫源地进行更多的研究,以便为疾病监测和控制的未来行动方针提供信息。
{"title":"Retrospective Analysis of Malaria Cases in a Potentially High Endemic Area of Morogoro Rural District, Eastern Tanzania.","authors":"Joseph N Aikambe,&nbsp;Ladslaus L Mnyone","doi":"10.2147/RRTM.S254577","DOIUrl":"https://doi.org/10.2147/RRTM.S254577","url":null,"abstract":"<p><strong>Background: </strong>Malaria is increasingly characterized by appreciable fine-scale variability in ecology and topography, and it is likely that we are missing some salient foci with unprecedented malaria transmission intensity in different parts of Tanzania. Therefore, efforts aimed at identifying area-specific malaria situation and intervening are needed to preserve the realized health gains and achieve elimination. Mkuyuni and Kiroka, adjacent wards within Morogoro Rural District, are purported to form one of such foci.</p><p><strong>Patients and methods: </strong>A retrospective study was conducted to determine six-year (2014-2019) malaria prevalence rates based on outpatients and laboratory registers obtained from two health facilities, one per ward, carrying out diagnosis of malaria either through microscopy or malaria rapid diagnostic test (mRDT). These data were checked for completeness before carrying out statistical analysis.</p><p><strong>Results: </strong>Overall, 35,386 (46.19%) out of 76,604 patients were positive for malaria. The average proportion of malaria cases was significantly higher in Mkuyuni (51.23%; n=19,438) than Kiroka (41.21%; n = 15,938) (P <0.001). Females were more affected than males (P <0.001);, and irrespective of the sex, most malaria cases were recorded in children <5 years of age (P <0.001) except at Mkuyuni. Malaria was recorded virtually all year round; however, the highest proportion of cases was recorded in April and July (P <0.001).</p><p><strong>Conclusion: </strong>This study revealed high malaria endemicity in Mkuyuni and Kiroka, with prevalence rate as high as 60.98%, which is far higher than the overall national average prevalence of 9%. More studies are needed in these and other putatively high endemic foci in Tanzania in order to inform the future course of action in disease surveillance and control.</p>","PeriodicalId":21138,"journal":{"name":"Research and Reports in Tropical Medicine","volume":"11 ","pages":"37-44"},"PeriodicalIF":3.1,"publicationDate":"2020-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2147/RRTM.S254577","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38102936","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Basic Coagulation Profiles and Platelet Count Among Schistosoma mansoni-Infected Adults Attending Sanja Primary Hospital, Northwest Ethiopia. 在埃塞俄比亚西北部桑贾初级医院就诊的曼氏血吸虫感染成人的基本凝血谱和血小板计数。
IF 3.1 Q2 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2020-04-22 eCollection Date: 2020-01-01 DOI: 10.2147/RRTM.S244912
Tahir Eyayu, Ayalew Jejaw Zeleke, Masresha Seyoum, Ligabaw Worku

Purpose: To assess basic coagulation profiles and platelet count among Schistosoma mansoni-infected and non-infected adults.

Patients and methods: A comparative cross-sectional study was conducted from February to April 2019 at Sanja Primary Hospital, northwest Ethiopia. A total of 200 adults (100 cases and 100 controls) were enrolled using convenient sampling technique. Both wet mount and Kato-Katz techniques were performed using a stool sample. The venous blood sample was collected to perform platelet count, basic coagulation and serological tests. The data were coded and entered into EpiData Manager (v4.4.2.1) and analyzed using SPSS version 20. Nonparametric tests were used during data analysis. P-value less than 0.05 was considered as statistically significant.

Results: Prothrombin time (PT), activated partial thromboplastin time (APTT) and international normalization ratio (INR) were significantly higher while the platelet count was significantly lower in S. mansoni-infected than healthy adults (P <0.001). There were statistically significant differences in the median [IQR] value of PT, APTT, INR and platelet count between light, moderate and heavy infected groups (P <0.05). Infection intensity had a positive correlation with basic coagulation profiles and a negative correlation with platelet count (P <0.05) of S. mansoni-infected adults.

Conclusion: The prevalence of coagulation abnormality was higher in S. mansoni-infected adults than healthy controls. Coagulation test and platelet count should be used to monitor and manage schistosomiasis-related complications.

目的:评估感染曼氏血吸虫和未感染曼氏血吸虫的成年人的基本凝血状况和血小板计数:2019 年 2 月至 4 月在埃塞俄比亚西北部的 Sanja 初级医院进行了一项横断面比较研究。研究采用方便抽样技术,共招募了 200 名成人(100 例病例和 100 例对照)。采用粪便样本进行湿装载和卡托-卡茨(Kato-Katz)技术。采集静脉血样本以进行血小板计数、基本凝血和血清学检测。数据经编码后输入 EpiData Manager(v4.4.2.1),并使用 SPSS 20 版进行分析。数据分析采用非参数检验。P 值小于 0.05 视为具有统计学意义:结果:曼氏痢疾杆菌感染成人的凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)和国际正常化比值(INR)明显高于健康成人,而血小板计数则明显低于健康成人(P P P 曼氏痢疾杆菌感染成人):结论:与健康对照组相比,曼森氏杆菌感染成人的凝血异常发生率更高。凝血试验和血小板计数应用于监测和处理血吸虫病相关并发症。
{"title":"Basic Coagulation Profiles and Platelet Count Among <i>Schistosoma mansoni</i>-Infected Adults Attending Sanja Primary Hospital, Northwest Ethiopia.","authors":"Tahir Eyayu, Ayalew Jejaw Zeleke, Masresha Seyoum, Ligabaw Worku","doi":"10.2147/RRTM.S244912","DOIUrl":"10.2147/RRTM.S244912","url":null,"abstract":"<p><strong>Purpose: </strong>To assess basic coagulation profiles and platelet count among <i>Schistosoma mansoni</i>-infected and non-infected adults.</p><p><strong>Patients and methods: </strong>A comparative cross-sectional study was conducted from February to April 2019 at Sanja Primary Hospital, northwest Ethiopia. A total of 200 adults (100 cases and 100 controls) were enrolled using convenient sampling technique. Both wet mount and Kato-Katz techniques were performed using a stool sample. The venous blood sample was collected to perform platelet count, basic coagulation and serological tests. The data were coded and entered into EpiData Manager (v4.4.2.1) and analyzed using SPSS version 20. Nonparametric tests were used during data analysis. <i>P</i>-value less than 0.05 was considered as statistically significant.</p><p><strong>Results: </strong>Prothrombin time (PT), activated partial thromboplastin time (APTT) and international normalization ratio (INR) were significantly higher while the platelet count was significantly lower in <i>S. mansoni</i>-infected than healthy adults (<i>P</i> <0.001). There were statistically significant differences in the median [IQR] value of PT, APTT, INR and platelet count between light, moderate and heavy infected groups (<i>P</i> <0.05). Infection intensity had a positive correlation with basic coagulation profiles and a negative correlation with platelet count (<i>P</i> <0.05) of <i>S. mansoni</i>-infected adults.</p><p><strong>Conclusion: </strong>The prevalence of coagulation abnormality was higher in <i>S. mansoni</i>-infected adults than healthy controls. Coagulation test and platelet count should be used to monitor and manage schistosomiasis-related complications.</p>","PeriodicalId":21138,"journal":{"name":"Research and Reports in Tropical Medicine","volume":"11 ","pages":"27-36"},"PeriodicalIF":3.1,"publicationDate":"2020-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ca/65/rrtm-11-27.PMC7184861.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37901663","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Parasitic Contamination of Fruits and Vegetables Collected from Local Markets of Bahir Dar City, Northwest Ethiopia. 从埃塞俄比亚西北部巴哈达尔市当地市场采集的水果和蔬菜中的寄生虫污染。
IF 3.1 Q2 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2020-03-25 eCollection Date: 2020-01-01 DOI: 10.2147/RRTM.S244737
Getaneh Alemu, Mezgebu Nega, Megbaru Alemu

Background: Fruits and vegetables, which are consumed raw, act as potential sources for the spread of various parasitic diseases. The rate of contamination and species of contaminant parasites varies based on climatic, ecological, and human factors. Therefore, local data about the contamination status and predisposing factors augments efforts for successful control of parasitic diseases.

Methods: A cross-sectional study was conducted on fruits and vegetables collected from local markets of Bahir Dar city from February to May 2019. A total of 384 samples were purchased from three randomly selected markets. Data on sociodemographic characteristics of vendors and factors associated with contamination of fruits and vegetables were collected using a structured questionnaire. About 200 g of fruit and vegetable samples were processed for parasites using direct wet mount and modified Zeihl-Neelson staining techniques following standard protocols. All data were analyzed using SPSS version 23.

Results: Among a total of 384 fruit and vegetable samples purchased from 112 vendors, 150 (39.1%) were contaminated with at least one species of parasite. Lettuce (56.4%) and mango (16.7%) were the most and the least commonly contaminated items respectively. Larva of Strongyloides species (13.5%) was the most frequently detected parasite followed by cysts of Entamoeba histolytica/E. dispar (12.8%). Contamination was more common in vegetables than fruits (AOR=2.968, p<0.001). Fruits and vegetables purchased from vendors with untrimmed fingernails (AOR=1.966, p=0.006), directly delivered from farmers (AOR=1.883, p=0.040), displayed in bucket with water (AOR=2.676, p=0.017) and those displayed without washing (AOR=5.511, p<0.001) were significantly associated with parasitic contamination.

Conclusion: The level of parasitic contamination of fruits and vegetables in Bahir Dar city is of public health importance. Hence, the public health sector should create public awareness in order to reduce parasitic transmission via fruits and vegetables.

背景:生食水果和蔬菜是各种寄生虫病的潜在传播源。污染率和污染寄生虫的种类因气候、生态和人为因素而异。因此,当地有关污染状况和易感因素的数据有助于成功控制寄生虫病:2019年2月至5月,对从巴哈达尔市当地市场收集的水果和蔬菜进行了横断面研究。从随机选择的三个市场共购买了 384 份样本。通过结构化问卷收集了有关商贩社会人口特征和果蔬污染相关因素的数据。对约 200 克果蔬样本进行了寄生虫检测,采用直接湿装片和改良 Zeihl-Neelson 染色技术,并按照标准方案进行了处理。所有数据均使用 SPSS 23 版进行分析:在从 112 个供应商处购买的 384 份水果和蔬菜样本中,有 150 份(39.1%)受到至少一种寄生虫的污染。生菜(56.4%)和芒果(16.7%)分别是最常见和最不常见的受污染产品。最常检测到的寄生虫是斯特龙线虫幼虫(13.5%),其次是组织溶解恩塔米巴虫/E. dispar 的囊蚴(12.8%)。蔬菜比水果更容易受到污染(AOR=2.968,pp=0.006),农户直接送货(AOR=1.883,pp=0.040),在有水的桶中摆放(AOR=2.676,pp=0.017)和未清洗就摆放(AOR=5.511,pp):巴哈达尔市水果和蔬菜的寄生虫污染程度对公共卫生具有重要意义。因此,公共卫生部门应提高公众意识,以减少寄生虫通过水果和蔬菜的传播。
{"title":"Parasitic Contamination of Fruits and Vegetables Collected from Local Markets of Bahir Dar City, Northwest Ethiopia.","authors":"Getaneh Alemu, Mezgebu Nega, Megbaru Alemu","doi":"10.2147/RRTM.S244737","DOIUrl":"10.2147/RRTM.S244737","url":null,"abstract":"<p><strong>Background: </strong>Fruits and vegetables, which are consumed raw, act as potential sources for the spread of various parasitic diseases. The rate of contamination and species of contaminant parasites varies based on climatic, ecological, and human factors. Therefore, local data about the contamination status and predisposing factors augments efforts for successful control of parasitic diseases.</p><p><strong>Methods: </strong>A cross-sectional study was conducted on fruits and vegetables collected from local markets of Bahir Dar city from February to May 2019. A total of 384 samples were purchased from three randomly selected markets. Data on sociodemographic characteristics of vendors and factors associated with contamination of fruits and vegetables were collected using a structured questionnaire. About 200 g of fruit and vegetable samples were processed for parasites using direct wet mount and modified Zeihl-Neelson staining techniques following standard protocols. All data were analyzed using SPSS version 23.</p><p><strong>Results: </strong>Among a total of 384 fruit and vegetable samples purchased from 112 vendors, 150 (39.1%) were contaminated with at least one species of parasite. Lettuce (56.4%) and mango (16.7%) were the most and the least commonly contaminated items respectively. Larva of <i>Strongyloides</i> species (13.5%) was the most frequently detected parasite followed by cysts of <i>Entamoeba histolytica/E. dispar</i> (12.8%). Contamination was more common in vegetables than fruits (AOR=2.968, <i>p</i><0.001). Fruits and vegetables purchased from vendors with untrimmed fingernails (AOR=1.966, <i>p</i>=0.006), directly delivered from farmers (AOR=1.883, <i>p</i>=0.040), displayed in bucket with water (AOR=2.676, <i>p</i>=0.017) and those displayed without washing (AOR=5.511, <i>p</i><0.001) were significantly associated with parasitic contamination.</p><p><strong>Conclusion: </strong>The level of parasitic contamination of fruits and vegetables in Bahir Dar city is of public health importance. Hence, the public health sector should create public awareness in order to reduce parasitic transmission via fruits and vegetables.</p>","PeriodicalId":21138,"journal":{"name":"Research and Reports in Tropical Medicine","volume":"11 ","pages":"17-25"},"PeriodicalIF":3.1,"publicationDate":"2020-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e8/62/rrtm-11-17.PMC7127876.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37825331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Geographic Accessibility, Readiness, and Barriers of Health Facilities to Offer Tuberculosis Services in East Gojjam Zone, Ethiopia: A Convergent Parallel Design. 埃塞俄比亚东Gojjam区卫生设施提供结核病服务的地理可及性、准备程度和障碍:趋同平行设计。
IF 3.1 Q2 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2020-02-04 eCollection Date: 2020-01-01 DOI: 10.2147/RRTM.S233052
Mulusew Andualem Asemahagn, Getu Degu Alene, Solomon Abebe Yimer

Background: Tuberculosis (TB) remains a foremost global public health threat. Active TB control needs geographically accessible health facilities that have quality diagnostics, equipment, supplies, medicines, and staff.

Objective: This study aimed at assessing the geographic distribution, physical accessibility, readiness and barriers of health facilities for TB services in East Gojjam zone, Ethiopia.

Methods: A convergent parallel design was applied using health facility and geographic data. Data on facility attributes, service availability and readiness were collected by inteviewing TB officers, laboratory heads and onsite facility visits. Coordinates of health facilities and kebele centroids were collected by GPS. We used ArcGIS 10.6 to measure Euclidean distance from each kebele centroids to the nearest health facility. Descriptive statistics were computed by using SPSS version 25. Barriers to TB service readiness were explored by in-depth interviews. NVivo12 was used to thematically analyze the qualitative data.

Results: The overall TB health service coverage (THSC) was 23% (ranging: 10-85%). The mean distance from the nearest health facility was 8km (ranging: 0.5-16km). About 132 (32%) kebeles had poor geographic accessibility to TB services (over 10km distance from the nearest health facility) and had poor facility readiness. Although 114 (95%) health facilities offered at least one TB service, 44 (38.6%) of them had no sputum smear microscopy. The overall TB readiness index was 63.5%: first-line anti-TB drugs (97%), diagnostics (63%), trained staffs, diagnostic and treatment guidelines (53%) and laboratory supplies (41%). Lack of health workers (laboratory personnel), inadequate budget, poor management practice and TB program support, inadequate TB commodity suppliers, and less accessible geographic locations of health facilities were identified as barriers to TB service readiness distribution.

Conclusion: Considerable proportion of the population in the study area  have poor access to quality TB diagnostic services due to low THSC and poor facility readiness. Barriers to TB service availability and readiness were health system related. Regular refresher training of health workers on TB, creating mechanisms to attract laboratory personnel to work in the study area and scaling up of sputum smear microscopy services, establishing an efficient mechanism for procurement, distribution, utilization and reporting of TB commodity supplies, and good management practices are crucial to enhance TB service readiness in the study zone.

背景:结核病(TB)仍然是全球最重要的公共卫生威胁。主动结核病控制需要地理上可及的卫生设施,这些设施拥有高质量的诊断、设备、用品、药品和工作人员。目的:本研究旨在评估埃塞俄比亚东Gojjam地区卫生设施结核病服务的地理分布、实际可及性、准备情况和障碍。方法:采用汇聚平行设计,采用卫生设施和地理资料。通过与结核病官员、实验室负责人面谈和实地设施访问,收集了有关设施属性、服务可用性和准备情况的数据。利用全球定位系统收集卫生设施的坐标和kebele质心。我们使用ArcGIS 10.6测量从每个kebele质心到最近的卫生设施的欧氏距离。描述性统计采用SPSS 25进行计算。通过深入访谈探讨了结核病服务准备的障碍。采用NVivo12对定性数据进行专题分析。结果:总体结核病卫生服务覆盖率(THSC)为23%(范围:10-85%)。到最近的卫生设施的平均距离为8公里(范围:0.5-16公里)。大约132个(32%)kebeles在地理上难以获得结核病服务(距离最近的卫生设施超过10公里),并且设施准备不足。虽然114家(95%)卫生机构至少提供一项结核病服务,但其中44家(38.6%)没有痰涂片镜检。总体结核病准备指数为63.5%:一线抗结核药物(97%)、诊断方法(63%)、训练有素的工作人员、诊断和治疗指南(53%)和实验室用品(41%)。缺乏卫生工作者(实验室人员)、预算不足、管理实践和结核病规划支持不力、结核病商品供应商不足以及卫生设施地理位置较差被确定为结核病服务准备分配的障碍。结论:由于THSC低和设施准备不足,研究地区相当大比例的人口难以获得高质量的结核病诊断服务。结核病服务提供和准备方面的障碍与卫生系统有关。对卫生工作者进行结核病定期进修培训,建立吸引实验室人员到研究地区工作的机制,扩大痰涂片显微镜服务,建立结核病商品供应的采购、分配、利用和报告的有效机制,以及良好的管理做法,对于加强研究地区的结核病服务准备至关重要。
{"title":"Geographic Accessibility, Readiness, and Barriers of Health Facilities to Offer Tuberculosis Services in East Gojjam Zone, Ethiopia: A Convergent Parallel Design.","authors":"Mulusew Andualem Asemahagn,&nbsp;Getu Degu Alene,&nbsp;Solomon Abebe Yimer","doi":"10.2147/RRTM.S233052","DOIUrl":"https://doi.org/10.2147/RRTM.S233052","url":null,"abstract":"<p><strong>Background: </strong>Tuberculosis (TB) remains a foremost global public health threat. Active TB control needs geographically accessible health facilities that have quality diagnostics, equipment, supplies, medicines, and staff.</p><p><strong>Objective: </strong>This study aimed at assessing the geographic distribution, physical accessibility, readiness and barriers of health facilities for TB services in East Gojjam zone, Ethiopia.</p><p><strong>Methods: </strong>A convergent parallel design was applied using health facility and geographic data. Data on facility attributes, service availability and readiness were collected by inteviewing TB officers, laboratory heads and onsite facility visits. Coordinates of health facilities and kebele centroids were collected by GPS. We used ArcGIS 10.6 to measure Euclidean distance from each kebele centroids to the nearest health facility. Descriptive statistics were computed by using SPSS version 25. Barriers to TB service readiness were explored by in-depth interviews. NVivo12 was used to thematically analyze the qualitative data.</p><p><strong>Results: </strong>The overall TB health service coverage (THSC) was 23% (ranging: 10-85%). The mean distance from the nearest health facility was 8km (ranging: 0.5-16km). About 132 (32%) kebeles had poor geographic accessibility to TB services (over 10km distance from the nearest health facility) and had poor facility readiness. Although 114 (95%) health facilities offered at least one TB service, 44 (38.6%) of them had no sputum smear microscopy. The overall TB readiness index was 63.5%: first-line anti-TB drugs (97%), diagnostics (63%), trained staffs, diagnostic and treatment guidelines (53%) and laboratory supplies (41%). Lack of health workers (laboratory personnel), inadequate budget, poor management practice and TB program support, inadequate TB commodity suppliers, and less accessible geographic locations of health facilities were identified as barriers to TB service readiness distribution.</p><p><strong>Conclusion: </strong>Considerable proportion of the population in the study area  have poor access to quality TB diagnostic services due to low THSC and poor facility readiness. Barriers to TB service availability and readiness were health system related. Regular refresher training of health workers on TB, creating mechanisms to attract laboratory personnel to work in the study area and scaling up of sputum smear microscopy services, establishing an efficient mechanism for procurement, distribution, utilization and reporting of TB commodity supplies, and good management practices are crucial to enhance TB service readiness in the study zone.</p>","PeriodicalId":21138,"journal":{"name":"Research and Reports in Tropical Medicine","volume":"11 ","pages":"3-16"},"PeriodicalIF":3.1,"publicationDate":"2020-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2147/RRTM.S233052","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37678727","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 23
期刊
Research and Reports in Tropical Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1